Development of novel thiazole-based hybrids as DNA gyrase inhibitors: design, synthesis, in silico and in vitro antibacterial evaluation

Vaghasiya, Mahesh D.; Mendapara, Jigarkumar V.; Ahmad, Iqrar; Patel, Harun; Rajani, Dhanji P.; Kumari, Premlata

doi:10.1007/s13738-024-03011-z

J IRAN CHEM SOC

2024

DOI: 10.1007/s13738-024-03011-z

|View full text |Cite

Development of novel thiazole-based hybrids as DNA gyrase inhibitors: design, synthesis, in silico and in vitro antibacterial evaluation

Mahesh D. Vaghasiya,

Jigarkumar V. Mendapara,

Iqrar Ahmad

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening

Vaghasiya,

Sain,

Mendapara

et al. 2024

Chemistry & Biodiversity

View full text Add to dashboard Cite

Novel thiazepine‐based hybrids (9a‐d) were designed and synthesized to create lead molecules with exceptional anti‐colon cancer efficacy. Analytical methods, including IR, NMR, and HR‐MS, characterized the synthesized compounds. The in vitro colorectal study was carried out to compare the biological activity of newly developed compounds with the computational data. The tested compounds induced cytotoxicity in HT‐29 cells for both 24h and 48h in a dose‐dependent manner. However, compound 9a induced cytotoxicity at much higher concentrations compared to the rest of the compounds. 9b and 9c caused 50% cell death (compared to the untreated cells) at a dose of ~ 50µM and 40 µM in case of 24‐hour exposure, respectively. On the contrary, for 48h exposure, both 9b and 9c induced 50% cell death concerning untreated cells at a dose of around ~20 µM, whereas 9d exhibited 50% cell death at 5 µM in the case of 48 h exposure. In silico ADMET was also carried out to understand the pharmacokinetics and safety profiles of the drug candidates. We found some of the critical targets of these compounds, which eventually will be integral to exploring the mechanistic actions of these compounds in colon cancer.

show abstract

Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening

Vaghasiya,

Sain,

Mendapara

et al. 2024

Chemistry & Biodiversity

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Development of novel thiazole-based hybrids as DNA gyrase inhibitors: design, synthesis, in silico and in vitro antibacterial evaluation

Cited by 1 publication

References 36 publications

Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening

Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening

Contact Info

Product

Resources

About